Overview

Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

Status:
Withdrawn
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if iloprost is effective in the treatment of elevated arterial pulmonary pressure in children with ventilator treated respiratory distress syndrome.
Phase:
N/A
Details
Lead Sponsor:
Lund University Hospital
Collaborator:
Bayer
Treatments:
Iloprost